Eczema on face treatment
Pro Research Analysisby 
Searched over 200M research papers
Effective Treatments for Eczema on the Face
Eczema, particularly atopic dermatitis (AD), is a chronic inflammatory skin condition that often affects the face, posing unique treatment challenges. This article synthesizes current research on effective treatments for facial eczema, focusing on systemic treatments, barrier repair therapies, and adjunctive treatments.
Systemic Treatments for Moderate to Severe Eczema
Biological Treatments: Dupilumab
Dupilumab, a biological treatment, has been identified as the most effective systemic treatment for moderate to severe eczema. It significantly reduces eczema symptoms and improves patient outcomes in the short term. Dupilumab has shown a high efficacy in achieving at least a 75% improvement in the Eczema Area and Severity Index (EASI75) and improving the Patient-Oriented Eczema Measure (POEM) scores . However, its long-term efficacy remains uncertain due to limited high-certainty evidence .
Other Immunosuppressive Agents
Other systemic immunosuppressive agents, such as tralokinumab and ustekinumab, have shown varying degrees of effectiveness. Tralokinumab may be effective in the short term, but there is insufficient evidence to support its long-term use . Ustekinumab's efficacy is uncertain due to very low-certainty evidence . Overall, the evidence for most other immunosuppressive treatments remains low or very low in certainty .
Barrier Repair Therapy
Non-Steroidal Emollient Creams
Barrier repair therapy using non-steroidal emollient creams has shown promise in treating facial eczema, especially in pediatric populations. A cream containing rhamnosoft, ceramides, and L-isoleucine (Nutratopic pro-AMP) has demonstrated significant clinical improvement in facial eczema symptoms in children. This treatment is well-tolerated and provides a steroid-free alternative for managing eczema on the face .
Topical Treatments
Corticosteroids and Calcineurin Inhibitors
Topical corticosteroids and calcineurin inhibitors are commonly used to reduce inflammation and restore the skin barrier. Proactive therapy, involving the twice-weekly application of these agents, can help prevent eczema flares . However, long-term use of corticosteroids on the face is limited due to the risk of skin atrophy .
Antimicrobial Treatments
Staphylococcus aureus colonization can exacerbate eczema. While topical steroid/antibiotic combinations may offer slight improvements in symptoms, the evidence is of low quality, and the risk of antibiotic resistance remains a concern . Bleach baths and other local antiseptic measures can be considered for patients with high bacterial colonization Chong2016George2019.
Adjunctive Treatments
Antihistamines
Oral H1 antihistamines, such as cetirizine and fexofenadine, are sometimes used as add-on therapy to reduce itching. However, their effectiveness in improving eczema symptoms is inconsistent, and they are generally not recommended as a primary treatment .
Traditional Chinese Medicine
Tripterygium agents, derived from Tripterygium wilfordii, have been used as supplemental therapy for eczema. While some studies suggest they may be effective when combined with other treatments, their use is limited by potential side effects, including reproductive system dysfunction .
Conclusion
Effective management of facial eczema involves a combination of systemic treatments, barrier repair therapies, and adjunctive treatments. Dupilumab stands out as the most effective systemic treatment for moderate to severe eczema, while non-steroidal emollient creams offer a promising steroid-free option for facial eczema. Topical corticosteroids and calcineurin inhibitors remain essential for reducing inflammation, but their long-term use on the face should be approached with caution. Further research is needed to establish the long-term efficacy and safety of these treatments.
Sources and full results
Most relevant research papers on this topic